Knockdown of mtdh sensitizes endometrial cancer cells to cell death induction by death receptor ligand trail and HDAC inhibitor LBH589 Co-treatment

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Meng, Xiangbing ^a,b   Brachova, Pavla ^a   Yang, Shujie ^a   Xiong, Zhi ^a   Zhang, Yuping ^a   Thiel, Kristina W ^a   Leslie, Kimberly K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CALBINDIN; GALECTIN 1; HISTONE DEACETYLASE; METADHERIN; ONCOPROTEIN; PANOBINOSTAT; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; APOPTOSIS REGULATORY PROTEIN; CELL ADHESION MOLECULE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; MTDH PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CALBINDIN 1 GENE; CANCER CELL; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CHEMOSENSITIVITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GALECTIN 1 GENE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; CELL CYCLE; CELL SURVIVAL; DRUG EFFECT; DRUG INTERACTION; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL ADHESION MOLECULES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG INTERACTIONS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 79958150318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020920     Document Type: Article

References (37)

1. Wei Y, Hu G, Kang Y, (2009) Metadherin as a link between metastasis and chemoresistance. Cell Cycle 8: 2132-2133.
2. Sarkar D, Emdad L, Lee SG, Yoo BK, Su ZZ, et al. (2009) Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res 69: 8529-8535.
3. Kwong LN, Chin L, (2009) The metastasis problem gets stickier. Cancer Cell 15: 1-2.
4. Hu G, Wei Y, Kang Y, (2009) The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 15: 5615-5620.
5. Thirkettle HJ, Mills IG, Whitaker HC, Neal DE, (2009) Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 28: 3663-3670.
6. Li J, Yang L, Song L, Xiong H, Wang L, et al. (2009) Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 28: 3188-3196.
7. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, et al. (2008) Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27: 1114-1121.
8. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, et al. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20.
9. Suehiro Y, Umayahara K, Ogata H, Numa F, Yamashita Y, et al. (2000) Genetic aberrations detected by comparative genomic hybridization predict outcome in patients with endometrioid carcinoma. Genes Chromosomes Cancer 29: 75-82.
10. Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen D, et al. (2009) Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci U S A 106: 12938-12943.
11. Liu H, Song X, Liu C, Xie L, Wei L, et al. (2009) Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 28: 19.
12. Holoch PA, Griffith TS, (2009) TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur J Pharmacol 625: 63-72.
13. Sadarangani A, Kato S, Espinoza N, Lange S, Llados C, et al. (2007) TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract. Apoptosis 12: 73-85.
14. Pallares J, Llobet D, Santacana M, Eritja N, Velasco A, et al. (2009) CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation. Am J Pathol 174: 287-296.
15. Llobet D, Eritja N, Encinas M, Llecha N, Yeramian A, et al. (2008) CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells. Oncogene 27: 2513-2524.
16. Dolcet X, Llobet D, Pallares J, Rue M, Comella JX, et al. (2005) FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis. Lab Invest 85: 885-894.
17. Aggarwal BB, Ichikawa H, (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4: 1201-1215.
18. Schuler S, Fritsche P, Diersch S, Arlt A, Schmid RM, et al. (2010) HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells. Mol Cancer 9: 80.
19. Darvas K, Rosenberger S, Brenner D, Fritsch C, Gmelin N, et al. (2010) Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression. Int J Cancer.
20. Carew JS, Giles FJ, Nawrocki ST, (2008) Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 269: 7-17.
21. VanOosten RL, Earel JK Jr, Griffith TS, (2007) Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity. Apoptosis 12: 561-571.
22. Fulda S, (2008) Modulation of TRAIL-induced apoptosis by HDAC inhibitors. Curr Cancer Drug Targets 8: 132-140.
23. Gadducci A, Tana R, Cosio S, Fanucchi A, Genazzani AR, (2008) Molecular target therapies in endometrial cancer: from the basic research to the clinic. Gynecol Endocrinol 24: 239-249.
24. Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, et al. (2009) Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res 7: 311-318.
25. Brown DM, Ruoslahti E, (2004) Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365-374.
26. Berggard T, Szczepankiewicz O, Thulin E, Linse S, (2002) Myo-inositol monophosphatase is an activated target of calbindin D28k. J Biol Chem 277: 41954-41959.
27. Shamir A, Elhadad N, Belmaker RH, Agam G, (2005) Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder. Bipolar Disord 7: 42-48.
28. Safrany ST, Wilcox RA, Liu C, Potter BV, Nahorski SR, (1992) 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition. Eur J Pharmacol 226: 265-272.
29. Camby I, Le Mercier M, Lefranc F, Kiss R, (2006) Galectin-1: a small protein with major functions. Glycobiology 16: 137R-157R.
30. Kauh J, Fan S, Xia M, Yue P, Yang L, et al. (2010) c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589. PLoS One 5: e10376.
31. Bluethner T, Niederhagen M, Caca K, Serr F, Witzigmann H, et al. (2007) Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach. World J Gastroenterol 13: 4761-4770.
32. Park JH, Jong HS, Kim SG, Jung Y, Lee KW, et al. (2008) Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase. J Mol Med 86: 117-128.
33. Dai D, Holmes AM, Nguyen T, Davies S, Theele DP, et al. (2005) A potential synergistic anticancer effect of paclitaxel and amifostine on endometrial cancer. Cancer Res 65: 9517-9524.
34. Meng X, Yue J, Liu Z, Shen Z, (2007) Abrogation of the transactivation activity of p53 by BCCIP down-regulation. J Biol Chem 282: 1570-1576.
35. Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK, (2008) WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Methods 73: 211-215.
36. Meng X, Lu H, Shen Z, (2004) BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1. Cell Cycle 3: 1457-1462.
37. Meng X, Fan J, Shen Z, (2007) Roles of BCCIP in chromosome stability and cytokinesis. Oncogene 26: 6253-6260.